Emiko Higashi - 18 Mar 2026 Form 3 Insider Report for TAKEDA PHARMACEUTICAL CO LTD (TAK)

Role
Director
Signature
/s/ Max Heuer, by power of attorney, for Emiko Higashi
Issuer symbol
TAK
Transactions as of
18 Mar 2026
Net transactions value
$0
Form type
3
Filing time
18 Mar 2026, 06:16:56 UTC
Previous filing
15 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Higashi Emiko Director C/O KLA CORPORATION, ONE TECHNOLOGY DRIVE, MILPITAS /s/ Max Heuer, by power of attorney, for Emiko Higashi 18 Mar 2026 0001318086

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding TAK American Depositary Shares 7,600 18 Mar 2026 Direct
holding TAK Ordinary Shares 17,800 18 Mar 2026 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TAK Tax Obligation Award 18 Mar 2026 Ordinary Shares 1,152 Direct F2
holding TAK Tax Obligation Award 18 Mar 2026 Ordinary Shares 1,192 Direct F2
holding TAK Tax Obligation Award 18 Mar 2026 Ordinary Shares 1,180 Direct F2
holding TAK Tax Obligation Award 18 Mar 2026 Ordinary Shares 3,432 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 12,800 restricted stock units (RSUs). Each RSU represents a contingent right to receive one Ordinary Share, which will be converted into an equivalent number of American Depositary Shares following vest. The RSUs vest on the following schedule: June 1, 2026 (3,100 shares), June 1, 2027 (3,400 shares), June 1, 2028 (3,200 shares) and upon conclusion of the director's board service (3,100 shares).
F2 Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares.
F3 Vests upon conclusion of the director's service on the board.

Remarks:

Exhibit 24 Power of Attorney